Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone

Clinical trial NCT00059631 · COMPLETED

Trial details

NCT number: NCT00059631
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2003-03-20
Primary completion: 2015-06-17
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.